Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Jan;53(1):80–81. doi: 10.1136/ard.53.1.80

Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha.

T Aoyagi, K Maeda, I Furuichi, K Eguchi, M Sakai, S Nagataki, K Iwasaki
PMCID: PMC1005250  PMID: 8311564

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eguchi K., Aoyagi T., Nakashima M., Migita K., Kawakami A., Tsukasaki K., Mine M., Maeda K., Nagataki S. A case of adult T cell leukemia complicated by proliferative synovitis. J Rheumatol. 1991 Feb;18(2):297–299. [PubMed] [Google Scholar]
  2. Eguchi K., Matsuoka N., Ida H., Nakashima M., Sakai M., Sakito S., Kawakami A., Terada K., Shimada H., Kawabe Y. Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis. 1992 Jun;51(6):769–776. doi: 10.1136/ard.51.6.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  4. Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 1991 Aug 30;253(5023):1026–1028. doi: 10.1126/science.1887217. [DOI] [PubMed] [Google Scholar]
  5. Kitajima I., Maruyama I., Maruyama Y., Ijichi S., Eiraku N., Mimura Y., Osame M. Polyarthritis in human T lymphotropic virus type I-associated myelopathy. Arthritis Rheum. 1989 Oct;32(10):1342–1344. doi: 10.1002/anr.1780321030. [DOI] [PubMed] [Google Scholar]
  6. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989 Feb 25;1(8635):441–441. doi: 10.1016/s0140-6736(89)90038-x. [DOI] [PubMed] [Google Scholar]
  7. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  8. Shibayama K., Nakamura T., Nagasato K., Shirabe S., Tsujihata M., Nagataki S. Interferon-alpha treatment in HTLV-I-associated myelopathy. Studies of clinical and immunological aspects. J Neurol Sci. 1991 Dec;106(2):186–192. doi: 10.1016/0022-510x(91)90256-7. [DOI] [PubMed] [Google Scholar]
  9. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031–2035. doi: 10.1073/pnas.79.6.2031. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES